Clinical Trial Update: Efficacity of Weekly Paclitaxel in Association or Not With Bevacizumab in Metastatic or Locally Advanced Angiosarcomas [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating weekly paclitaxel with or without bevacizumab in metastatic or locally advanced angiosarcoma has completed and reported efficacy result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angiosarcoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Centre Oscar Lambret | Conditions: Angiosarcoma | Phase 2 | Status: COMPLETED